|
Volumn 46, Issue 9, 2011, Pages 3917-3925
|
Synthesis and biological evaluation of 1-substituted-3(5)-(6-methylpyridin- 2-yl)-4-(quinoxalin-6-yl)pyrazoles as transforming growth factor-β type 1 receptor kinase inhibitors
|
Author keywords
ALK5 inhibitor; Cancer; Cell based luciferase reporter assay; Docking; Fibrosis; Kinase assay; TGF
|
Indexed keywords
1 (6 METHYLPYRIDIN 2 YL) 2 (QUINOXALIN 6 YL)ETHANONE;
2 (2,3 DIMETHYLQUINOXALIN 6 YL) 1 (6 METHYLPYRIDIN 2 YL)ETHANO;
2 [3 (6 METHYLPYRIDIN 2 YL) 4 (QUINOXALIN 6 YL) 1H PYRAZOL 1 YL]N PHENYLACETAMIDE;
2 [3 (6 METHYLPYRIDIN 2 YL) 4 (QUINOXALIN 6 YL) 1H PYRAZOL 1 YL]N PHENYLETHANETHIOAMIDE;
2 [4 (2,3 DIMETHYLQUINOXALIN 6 YL) 3 (6 METHYLPYRIDIN 2 YL) 1H PYRAZOL 1 YL]N PHENYLACETAMIDE;
2 [4 (2,3 DIMETHYLQUINOXALIN 6 YL) 3 (6 METHYLPYRIDIN 2 YL) 1H PYRAZOL 1 YL]N PHENYLETHANETHIOAMIDE;
2 [4 (2,3 DIMETHYLQUINOXALIN 6 YL) 5 (6 METHYLPYRIDIN 2 YL) 1H PYRAZOL 1 YL]N PHENYLACETAMIDE;
2 [5 (6 METHYLPYRIDIN 2 YL) 4 (QUINOXALIN 6 YL) 1H PYRAZOL 1 YL]N PHENYLACETAMIDE;
2,3 DIMETHYL 6 [3 (6 METHYLPYRIDIN 2 YL) 1H PYRAZOL 4 YL]QUINOXALINE;
3 [2 [3 (6 METHYLPYRIDIN 2 YL) 4 (QUINOXALIN 6 YL) 1H PYRAZOL 1 YL]ACETAMIDO]BENZAMIDE;
3 [2 [4 (2,3 DIMETHYLQUINOXALIN 6 YL) 3 (6 METHYLPYRIDIN 2 YL) 1H PYRAZOL 1 YL]ACETAMIDO]BENZAMIDE;
3 [3 (6 METHYLPYRIDIN 2 YL) 4 (QUINOXALIN 6 YL) 1H PYRAZOL 1 YL]N PHENYLPROPANAMIDE;
3 BROMO N(3 CYANOPHENYL)PROPANAMIDE;
6 [3 (6 METHYLPYRIDIN 2 YL) 1H PYRAZOL 4 YL]QUINOXALINE;
A 83 01;
ENZYME INHIBITOR;
GW 6604;
IN 1130;
IN 1233;
LY 2157299;
MITOGEN ACTIVATED PROTEIN KINASE P38;
N (3 CYANOPHENYL) 2 [3 (6 METHYLPYRIDIN 2 YL) 4 (QUINOXALIN 6 YL) 1H PYRAZOL 1 YL];
N (3 CYANOPHENYL) 2 [4 (2,3 DIMETHYLQUINOXALIN 6 YL) 3 (6 METHYLPYRIDIN 2 YL) 1H PYRAZOL 1 YL]ACETAMIDE;
N (3 CYANOPHENYL) 2 [4 (2,3 DIMETHYLQUINOXALIN 6 YL) 5 (6 METHYLPYRIDIN 2 YL) 1H PYRAZOL 1 YL]ACETAMIDE;
N (3 CYANOPHENYL) 2 [5 (6 METHYPYRIDIN 2 YL) 4 (QUINOXALIN 6 YL) 1H PYRAZOL 1 YL]ACETAMIDE;
N (3 CYANOPHENYL) 3 [4 (2,3 DIMETHYLQUINOXALIN 6 YL) 3 (6 METHYLPYRIDIN 2 YL) 1H PYRAZOL 1 YLPROPANAMIDE;
N(3 CYANOPHENYL) 2 [3 (6 METHYLPYRIDIN 2 YL) 4 (QUINOXALIN 6 YL) 1H PYRAZOL 1 YLETHANETHIOAMIDE;
N(3 CYANOPHENYL) 2 [4 (2,3 DIMETHYLQUINOXALIN 6 YL) 3 (6 METHYLPYRIDIN 2 YL) 1H PYRAZOL 1 YL]ETHANETHIOAMIDE;
PYRAZOLE DERIVATIVE;
SB 505124;
SB 525234;
SD 208;
TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1;
TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1 INHIBITOR;
UNCLASSIFIED DRUG;
ARTICLE;
CONTROLLED STUDY;
DRUG BINDING;
DRUG SYNTHESIS;
ENZYME ACTIVE SITE;
ENZYME ASSAY;
ENZYME INHIBITION;
ENZYME PHOSPHORYLATION;
EVALUATION;
IC 50;
SUBSTITUTION REACTION;
ANIMALS;
CELL LINE;
HUMANS;
MAGNETIC RESONANCE SPECTROSCOPY;
MODELS, MOLECULAR;
PHOSPHORYLATION;
PROTEIN KINASE INHIBITORS;
PROTEIN-SERINE-THREONINE KINASES;
PYRAZOLES;
RECEPTORS, TRANSFORMING GROWTH FACTOR BETA;
SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;
X-RAY DIFFRACTION;
|
EID: 80052951712
PISSN: 02235234
EISSN: 17683254
Source Type: Journal
DOI: 10.1016/j.ejmech.2011.05.063 Document Type: Article |
Times cited : (34)
|
References (45)
|